NCT03508882View on ClinicalTrials.gov

Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

February 20, 2019

Conditions
BlepharospasmHemifacial SpasmBotulinum Toxins, Type A
Interventions
DRUG

Botulinum Toxin Type A 100Unit/Vial (Product)

Botulinum Toxin Type A 100Unit/Vial (Product) comes as a dry powder and is routinely reconstituted with Saline Solution for Injection

DRUG

Saline Solution for Injection

The placebo consists of vehicle only. Saline Solution for Injection is the vehicle substance normally used to reconstitute Botulinum Toxin Type A (see 1st Intervention above).

All Listed Sponsors
collaborator

Food and Health Bureau, Hong Kong

OTHER_GOV

lead

The University of Hong Kong

OTHER

NCT03508882 - Pretarsal Versus Preseptal Botulinum Toxin for Patients With Eyelid Spasm | Biotech Hunter | Biotech Hunter